SCHEMBL6544202

SCHEMBL6544202

Cc1cc(Oc2ccc(N)c(N(C)C(=O)OC(C)(C)C)c2)c(C)cc1O

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.32
RXRA P19793 1/20 0.31
BRD4 O60885 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6543660 0.87 ESRRA (0.37) ABL1BRD4
SCHEMBL6543097 0.87 PGR (0.33) ABL1
SCHEMBL6544812 0.84 ESRRA (0.33) ABL1
SCHEMBL28786462 0.84 CARM1 (0.37) ABL1
SCHEMBL27782470 0.84 HPGD (0.39)
SCHEMBL6543795 0.84 AR (0.36) BRD4
SCHEMBL27782482 0.83 ABL1 (0.37) ABL1
SCHEMBL6544015 0.83 ALDH1A1 (0.34)
SCHEMBL27939698 0.82 KMT2A (0.37) ABL1BRD4
SCHEMBL15930785 0.81 ABL1 (0.35) ABL1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1022272-B1 SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS SANKYO CO (JP) 2004-05-26 EP disclosed
US-6432993-B1 BENZIMIDAZOLE OR IMIDAZO(4,5-B)PYRIDINE DERIVATES; IMMUNOMODULATORS; ALDOSE REDUCTASE AND LIPOXYGENASE INHIBITORS; DIABETES; PREVENTS LIPID PEROXIDATION; ANTILIPEMIC, HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 2002-08-13 US disclosed
EP-1022272-A1 SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS Sankyo Company Limited (JP) 2000-07-26 EP disclosed